Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Burn

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Journal of Neurology|July 1, 1992
Langerhans' cell histiocytosis and the nervous systemD J Burn, J D Watson, M Roddie, et al.
Brain : a Journal of Neurology|August 1, 1995
Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET studyD J Burn, J O Rinne, N P Quinn, et al.
Annals of Neurology|May 1, 1995
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophyJ O Rinne, D J Burn, C J Mathias, et al.
Acta Neurologica Scandinavica|May 1, 1997
Striatal dopaminergic loss without parkinsonism in a case of corticobasal degenerationE F Marshall, R H Perry, E K Perry, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 15, 2016
Short latency afferent inhibition: Effects of ageingA J Yarnall, B S W Ho, E Eshun, et al.
Brain : a Journal of Neurology|June 16, 2001
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UKU Nath, Y Ben-Shlomo, R G Thomson, et al.
Annals of Neurology|July 17, 1998
Olivopontocerebellar atrophy and multiple system atrophy: clinical follow-up of 10 patients studied with PETA Schrag, J O Rinne, D J Burn, et al.
Psychological Medicine|October 24, 2015
Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysisS Landau, V Harris, D J Burn, et al.
Neurology|July 1, 1994
The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's diseaseG V Sawle, D J Burn, P K Morrish, et al.
International Journal of Geriatric Psychiatry|December 8, 2016
Cognitive impairment in Parkinson's disease: impact on quality of life of carersR A Lawson, A J Yarnall, F Johnston, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Journal of Neurology|July 1, 1992
Langerhans' cell histiocytosis and the nervous systemD J Burn, J D Watson, M Roddie, et al.
Brain : a Journal of Neurology|August 1, 1995
Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET studyD J Burn, J O Rinne, N P Quinn, et al.
Annals of Neurology|May 1, 1995
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophyJ O Rinne, D J Burn, C J Mathias, et al.
Acta Neurologica Scandinavica|May 1, 1997
Striatal dopaminergic loss without parkinsonism in a case of corticobasal degenerationE F Marshall, R H Perry, E K Perry, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 15, 2016
Short latency afferent inhibition: Effects of ageingA J Yarnall, B S W Ho, E Eshun, et al.
Brain : a Journal of Neurology|June 16, 2001
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UKU Nath, Y Ben-Shlomo, R G Thomson, et al.
Annals of Neurology|July 17, 1998
Olivopontocerebellar atrophy and multiple system atrophy: clinical follow-up of 10 patients studied with PETA Schrag, J O Rinne, D J Burn, et al.
Psychological Medicine|October 24, 2015
Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysisS Landau, V Harris, D J Burn, et al.
Neurology|July 1, 1994
The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's diseaseG V Sawle, D J Burn, P K Morrish, et al.
International Journal of Geriatric Psychiatry|December 8, 2016
Cognitive impairment in Parkinson's disease: impact on quality of life of carersR A Lawson, A J Yarnall, F Johnston, et al.
Pageof 9